| Business Summary | | InforMax
Inc.
is
a
global
provider
of
bioinformatic
software
solutions,
involving
the
application
of
information
technology
to
the
analysis
of
genomic,
proteomic
and
other
biomolecular
data.
The
Company's
bioinformatic
software
solutions
are
designed
to
enable
researchers
to
more
efficiently
search,
organize,
share,
analyze
and
interpret
these
data
that
form
the
genetic
blueprint
of
all
organisms.
As
a
result,
the
Company's
solutions
allow
researchers
to
reduce
the
time
it
takes
to
discover
and
validate
biological
targets
that
may
lead
to
new
therapeutics,
diagnostics
or
biomolecular
interventions
to
cure
or
prevent
disease. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | InforMax,
Inc.
is
a
global
provider
of
bioinformatic
software
solutions
for
the
analysis
and
interpretation
of
genomic,
proteomic
and
other
biomolecular
data.
For
the
six
months
ended
6/30/01,
revenues
totalled
$14.2
million,
up
from
$6.5
million.
Net
loss
applicable
to
Common
rose
29%
to
$8.1
million.
Revenues
reflect
an
increase
in
Vector
NTI
Suite
sales
and
increased
demand
for
the
GenoMax
enterprise
product.
Higher
loss
reflects
an
increase
in
salaries
and
benefits. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Alex Titomirov, Ph.D., 41 Chairman,
CEO | $367K | $13.8M | James Bernstein, M.D., 62 Pres,
COO, Director | 325K | 1.2M | John Green, 49 CFO,
Sr. VP-Fin. and Admin. | -- | -- | Timothy Sullivan, 41 Sr.
VP of Sales and Marketing | 348K | 513K | Stephen Lincoln, 36 Sr.
VP of Product Devel.. | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|